On the eve of a trial with a former employee turned whistleblower, biotechnology company Biogen agreed to pay $900 million to settle allegations of lavishly overpaying doctors to prescribe their drugs to Multiple Sclerosis patients. | Poal: Say what you want.

Welcome • User Guide
ToS • Privacy • Canary
Donate • Bugs • License

©2025 Poal.co

727

•

On the eve of a trial with a former employee turned whistleblower, biotechnology company Biogen agreed to pay $900 million to settle allegations of lavishly overpaying doctors to prescribe their drugs to Multiple Sclerosis patients. (www.natlawreview.com)

(post is archived)

You are currently inside a comment thread.

Click here to see all the comments (4).

[–] • 2 pts

(edited )

Your child has a mineral deficiency. Give selenium, look up dosage. Seriously.

https://pubmed.ncbi.nlm.nih.gov/2484516/

parent
link